Response to Salvage Treatment in Recurrent Ovarian Cancer Treated Initially with Paclitaxel and Platinum-Based Combination Regimens
- 28 February 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 68 (2), 178-182
- https://doi.org/10.1006/gyno.1997.4909
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II StudyGynecologic Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Salvage Chemotherapy for Epithelial Ovarian CarcinomaGynecologic Oncology, 1994
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.Journal of Clinical Oncology, 1993
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990
- Survival of patients with ovarian epithelial carcinomas after second-look laparotomyGynecologic Oncology, 1990
- Survival after second-look laparotomy in advanced ovarian epithelial cancer: Study of 86 patientsEuropean Journal of Cancer and Clinical Oncology, 1989